email article
Keeping newborns on antiseizure medication after acute neonatal seizures stopped did not change development outcomes or prevent epilepsy, a comparative effectiveness study showed.
No difference was seen in functional neurodevelopment at age 24 months in children whose antiseizure medication was discontinued versus maintained after acute symptomatic neonatal seizures resolved, reported Hannah Glass, MDCM, MAS, of the University of California San Francisco, and co-authors, in
Overall, 13% of children developed epilepsy, which was not associated with treatment duration. Median age at epilepsy onset was 7 months. More than 16,000 babies in the U.S. have seizures each year due to a variety of causes, most commonly brain injury around the time of birth, Glass said. Many of these children have lifelong disabilities and medical conditions like cerebral palsy and epilepsy, she told
email article
Ten years after breast cancer diagnosis, women with multiple sclerosis (MS) had higher mortality than women without MS, a Canadian case-control study showed.
MS was associated with a 28% increased hazard for all-cause mortality (HR 1.28, 95% CI 1.08-1.53), but not with cancer-specific survival (HR 0.98, 95% CI 0.65-1.46), reported Ruth Ann Marrie, MD, PhD, of the University of Manitoba in Winnipeg, and colleagues in Although multiple sclerosis and its complications remain the most common cause of death in people with MS, cancer is the second or third most common cause of death, Marrie said in a statement. Our study looked at whether survival rates for women after a breast cancer diagnosis were different for those with MS and those without it.
Haze May Be Clearing in Parkinson s Disease medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
For MedPage Today s After the Pandemic series, we asked our editorial board members to discuss what significant and lasting effects the COVID-19 pandemic will have on medicine and the delivery of healthcare.
Here, we interview Beth Darnall, PhD, associate professor in the department of anesthesiology, perioperative, and pain medicine at Stanford University School of Medicine and director of the Stanford Pain Relief Innovations Lab in Palo Alto, California.
Can you share an anecdote about a patient and how the pandemic affected his or her situation?
Darnall: This story is about a person who is not my patient but whose care I am deeply aware of. Her medical emergency was a confluence of the pandemic and the ice storms that occurred in Texas several months ago.